Shiro Mita
Oprichter bij M's Science Corp.
Profiel
Shiro Mita is the founder of M's Science Corp.
established in 2000, where he holds the title of Representative Director.
Dr. Mita obtained a doctorate degree from the University of Tokyo.
Actieve functies van Shiro Mita
| Bedrijven | Functie | Begin |
|---|---|---|
M's Science Corp.
 M's Science Corp. Miscellaneous Commercial ServicesCommercial Services M's Science Corp. engages in the research and development of drugs for the treatment of central nervous system (CNS) disorders and ocular diseases. It develops Cutamesine, an orally active compound that enhances neuroregeneration and facilitates the recovery of damaged CNS tissues from stress or ischemia-induced insults. The firm also develops therapeutic drugs for oncology. The company was founded by Shiro Mita in November 2000 and is headquartered in Kobe, Japan. | Oprichter | 01-11-2000 |
Eerdere bekende functies van Shiro Mita
| Bedrijven | Functie | Einde |
|---|---|---|
| KUBOTA PHARMACEUTICAL HOLDINGS CO., LTD. | Directeur/Bestuurslid | - |
| SANTEN PHARMACEUTICAL CO., LTD. | Directeur/Bestuurslid | - |
| ACUCELA INC | Directeur/Bestuurslid | - |
| Keio University | Corporate Officer/Principal | - |
Opleiding van Shiro Mita
| University of Tokyo | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| SANTEN PHARMACEUTICAL CO., LTD. | Health Technology |
| KUBOTA PHARMACEUTICAL HOLDINGS CO., LTD. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
M's Science Corp.
M's Science Corp. Miscellaneous Commercial ServicesCommercial Services M's Science Corp. engages in the research and development of drugs for the treatment of central nervous system (CNS) disorders and ocular diseases. It develops Cutamesine, an orally active compound that enhances neuroregeneration and facilitates the recovery of damaged CNS tissues from stress or ischemia-induced insults. The firm also develops therapeutic drugs for oncology. The company was founded by Shiro Mita in November 2000 and is headquartered in Kobe, Japan. | Commercial Services |
Acucela, Inc.
 Acucela, Inc. Pharmaceuticals: MajorHealth Technology Acucela, Inc. operates as a clinical-stage biotechnology company. It discovers and develops novel therapeutics to treat and show the progression of sight-threatening ophthalmic diseases. Its pipeline includes drug candidates and therapeutics for the treatment of age related macular degeneration, cataracts, presbyopia, diabetic retinopathy, retinitis igmentosa and Stargardt disease. The company was founded by Ryo Kubota in April 2002 and is headquartered in Seattle, WA. | Health Technology |
